Balkees Abderrahman on exhaled breath biopsy for cancer diagnosis


Balkees Abderrahman (MD Anderson Cancer Center, TX, USA, and the University of Leeds, West Yorkshire, UK) discusses the latest developments in exhaled breath biopsy tests, the clinical trials underway that are testing them and the future applications for this technique in cancer diagnosis.    Could you please describe the exhaled breath biopsy diagnostic technique? Exhaled breath is infused with volatile organic compounds (VOCs). These are carbon-containing compounds that are volatile enough to be detectable in the gas phase at room temperature.  Many diseases, including certain cancers, have altered cellular metabolisms, which can potentially generate disease-indicative (or biomarker) VOCs that can be our roadmap to their early diagnosis. As one example, small-bowel bacteria overgrowth is associated...

To view this content, please register now for access

Join our member community for FREE to access a collection of journal and online-only features, including:

  • Exclusive access to educational videos, eBooks and insights into top BioTechniques journal articles
  • The latest news and journal updates delivered straight to your inbox when you want it
  • Personalized recommendations for the latest member-exclusive podcasts, interviews and expert opinions
  • Priority registration to webinars, panel discussions and events
  • Access to competitions and journal publication discounts, including 10% off open access fees when you sign up today!